Secondary Prevention of Acute Coronary Events. Reduction of Cholesterol to Key European Targets [SPACE-ROCKET] - An open-label comparative investigation of efficacy, tolerance and health in 2,072 patients randomised to rosuvastatin or
Phase of Trial: Phase III
Latest Information Update: 11 Mar 2010
At a glance
- Drugs Rosuvastatin; Simvastatin
- Indications Acute coronary syndromes; Dyslipidaemias; Hypercholesterolaemia; Myocardial infarction; Myocardial ischaemia
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms SPACE-ROCKET
- 11 Mar 2010 Actual end date (30 Apr 2006) added as reported by ClinicalTrials.gov.
- 10 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 11 Nov 2008 Results of a SPACE-ROCKET pharmacogenomics substudy presented at AHA 2008.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History